1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hepatitis Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Hepatitis Vaccine 1.2.3 Anti-Viral Drugs 1.3 Market by Application 1.3.1 Global Hepatitis Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hepatitis A 1.3.3 Hepatitis B 1.3.4 Hepatitis C 1.3.5 Alcoholic Hepatitis 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Hepatitis Therapeutics Market Perspective (2018-2029) 2.2 Hepatitis Therapeutics Growth Trends by Region 2.2.1 Global Hepatitis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Hepatitis Therapeutics Historic Market Size by Region (2018-2023) 2.2.3 Hepatitis Therapeutics Forecasted Market Size by Region (2024-2029) 2.3 Hepatitis Therapeutics Market Dynamics 2.3.1 Hepatitis Therapeutics Industry Trends 2.3.2 Hepatitis Therapeutics Market Drivers 2.3.3 Hepatitis Therapeutics Market Challenges 2.3.4 Hepatitis Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hepatitis Therapeutics Players by Revenue 3.1.1 Global Top Hepatitis Therapeutics Players by Revenue (2018-2023) 3.1.2 Global Hepatitis Therapeutics Revenue Market Share by Players (2018-2023) 3.2 Global Hepatitis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hepatitis Therapeutics Revenue 3.4 Global Hepatitis Therapeutics Market Concentration Ratio 3.4.1 Global Hepatitis Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hepatitis Therapeutics Revenue in 2022 3.5 Hepatitis Therapeutics Key Players Head office and Area Served 3.6 Key Players Hepatitis Therapeutics Product Solution and Service 3.7 Date of Enter into Hepatitis Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hepatitis Therapeutics Breakdown Data by Type 4.1 Global Hepatitis Therapeutics Historic Market Size by Type (2018-2023) 4.2 Global Hepatitis Therapeutics Forecasted Market Size by Type (2024-2029) 5 Hepatitis Therapeutics Breakdown Data by Application 5.1 Global Hepatitis Therapeutics Historic Market Size by Application (2018-2023) 5.2 Global Hepatitis Therapeutics Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Hepatitis Therapeutics Market Size (2018-2029) 6.2 North America Hepatitis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Hepatitis Therapeutics Market Size by Country (2018-2023) 6.4 North America Hepatitis Therapeutics Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Hepatitis Therapeutics Market Size (2018-2029) 7.2 Europe Hepatitis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Hepatitis Therapeutics Market Size by Country (2018-2023) 7.4 Europe Hepatitis Therapeutics Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hepatitis Therapeutics Market Size (2018-2029) 8.2 Asia-Pacific Hepatitis Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Hepatitis Therapeutics Market Size by Region (2018-2023) 8.4 Asia-Pacific Hepatitis Therapeutics Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Hepatitis Therapeutics Market Size (2018-2029) 9.2 Latin America Hepatitis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Hepatitis Therapeutics Market Size by Country (2018-2023) 9.4 Latin America Hepatitis Therapeutics Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hepatitis Therapeutics Market Size (2018-2029) 10.2 Middle East & Africa Hepatitis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Hepatitis Therapeutics Market Size by Country (2018-2023) 10.4 Middle East & Africa Hepatitis Therapeutics Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Gilead 11.1.1 Gilead Company Detail 11.1.2 Gilead Business Overview 11.1.3 Gilead Hepatitis Therapeutics Introduction 11.1.4 Gilead Revenue in Hepatitis Therapeutics Business (2018-2023) 11.1.5 Gilead Recent Development 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Detail 11.2.2 Johnson & Johnson Business Overview 11.2.3 Johnson & Johnson Hepatitis Therapeutics Introduction 11.2.4 Johnson & Johnson Revenue in Hepatitis Therapeutics Business (2018-2023) 11.2.5 Johnson & Johnson Recent Development 11.3 Bristol-Myers Squibb Company 11.3.1 Bristol-Myers Squibb Company Company Detail 11.3.2 Bristol-Myers Squibb Company Business Overview 11.3.3 Bristol-Myers Squibb Company Hepatitis Therapeutics Introduction 11.3.4 Bristol-Myers Squibb Company Revenue in Hepatitis Therapeutics Business (2018-2023) 11.3.5 Bristol-Myers Squibb Company Recent Development 11.4 Merck & Co.Inc. 11.4.1 Merck & Co.Inc. Company Detail 11.4.2 Merck & Co.Inc. Business Overview 11.4.3 Merck & Co.Inc. Hepatitis Therapeutics Introduction 11.4.4 Merck & Co.Inc. Revenue in Hepatitis Therapeutics Business (2018-2023) 11.4.5 Merck & Co.Inc. Recent Development 11.5 AbbVie Inc. 11.5.1 AbbVie Inc. Company Detail 11.5.2 AbbVie Inc. Business Overview 11.5.3 AbbVie Inc. Hepatitis Therapeutics Introduction 11.5.4 AbbVie Inc. Revenue in Hepatitis Therapeutics Business (2018-2023) 11.5.5 AbbVie Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hepatitis Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Hepatitis Vaccine Table 3. Key Players of Anti-Viral Drugs Table 4. Global Hepatitis Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 5. Global Hepatitis Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Hepatitis Therapeutics Market Size by Region (2018-2023) & (US$ Million) Table 7. Global Hepatitis Therapeutics Market Share by Region (2018-2023) Table 8. Global Hepatitis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global Hepatitis Therapeutics Market Share by Region (2024-2029) Table 10. Hepatitis Therapeutics Market Trends Table 11. Hepatitis Therapeutics Market Drivers Table 12. Hepatitis Therapeutics Market Challenges Table 13. Hepatitis Therapeutics Market Restraints Table 14. Global Hepatitis Therapeutics Revenue by Players (2018-2023) & (US$ Million) Table 15. Global Hepatitis Therapeutics Market Share by Players (2018-2023) Table 16. Global Top Hepatitis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Therapeutics as of 2022) Table 17. Ranking of Global Top Hepatitis Therapeutics Companies by Revenue (US$ Million) in 2022 Table 18. Global 5 Largest Players Market Share by Hepatitis Therapeutics Revenue (CR5 and HHI) & (2018-2023) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hepatitis Therapeutics Product Solution and Service Table 21. Date of Enter into Hepatitis Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hepatitis Therapeutics Market Size by Type (2018-2023) & (US$ Million) Table 24. Global Hepatitis Therapeutics Revenue Market Share by Type (2018-2023) Table 25. Global Hepatitis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global Hepatitis Therapeutics Revenue Market Share by Type (2024-2029) Table 27. Global Hepatitis Therapeutics Market Size by Application (2018-2023) & (US$ Million) Table 28. Global Hepatitis Therapeutics Revenue Market Share by Application (2018-2023) Table 29. Global Hepatitis Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global Hepatitis Therapeutics Revenue Market Share by Application (2024-2029) Table 31. North America Hepatitis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 32. North America Hepatitis Therapeutics Market Size by Country (2018-2023) & (US$ Million) Table 33. North America Hepatitis Therapeutics Market Size by Country (2024-2029) & (US$ Million) Table 34. Europe Hepatitis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 35. Europe Hepatitis Therapeutics Market Size by Country (2018-2023) & (US$ Million) Table 36. Europe Hepatitis Therapeutics Market Size by Country (2024-2029) & (US$ Million) Table 37. Asia-Pacific Hepatitis Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 38. Asia-Pacific Hepatitis Therapeutics Market Size by Region (2018-2023) & (US$ Million) Table 39. Asia-Pacific Hepatitis Therapeutics Market Size by Region (2024-2029) & (US$ Million) Table 40. Latin America Hepatitis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 41. Latin America Hepatitis Therapeutics Market Size by Country (2018-2023) & (US$ Million) Table 42. Latin America Hepatitis Therapeutics Market Size by Country (2024-2029) & (US$ Million) Table 43. Middle East & Africa Hepatitis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 44. Middle East & Africa Hepatitis Therapeutics Market Size by Country (2018-2023) & (US$ Million) Table 45. Middle East & Africa Hepatitis Therapeutics Market Size by Country (2024-2029) & (US$ Million) Table 46. Gilead Company Detail Table 47. Gilead Business Overview Table 48. Gilead Hepatitis Therapeutics Product Table 49. Gilead Revenue in Hepatitis Therapeutics Business (2018-2023) & (US$ Million) Table 50. Gilead Recent Development Table 51. Johnson & Johnson Company Detail Table 52. Johnson & Johnson Business Overview Table 53. Johnson & Johnson Hepatitis Therapeutics Product Table 54. Johnson & Johnson Revenue in Hepatitis Therapeutics Business (2018-2023) & (US$ Million) Table 55. Johnson & Johnson Recent Development Table 56. Bristol-Myers Squibb Company Company Detail Table 57. Bristol-Myers Squibb Company Business Overview Table 58. Bristol-Myers Squibb Company Hepatitis Therapeutics Product Table 59. Bristol-Myers Squibb Company Revenue in Hepatitis Therapeutics Business (2018-2023) & (US$ Million) Table 60. Bristol-Myers Squibb Company Recent Development Table 61. Merck & Co.Inc. Company Detail Table 62. Merck & Co.Inc. Business Overview Table 63. Merck & Co.Inc. Hepatitis Therapeutics Product Table 64. Merck & Co.Inc. Revenue in Hepatitis Therapeutics Business (2018-2023) & (US$ Million) Table 65. Merck & Co.Inc. Recent Development Table 66. AbbVie Inc. Company Detail Table 67. AbbVie Inc. Business Overview Table 68. AbbVie Inc. Hepatitis Therapeutics Product Table 69. AbbVie Inc. Revenue in Hepatitis Therapeutics Business (2018-2023) & (US$ Million) Table 70. AbbVie Inc. Recent Development Table 71. Research Programs/Design for This Report Table 72. Key Data Information from Secondary Sources Table 73. Key Data Information from Primary Sources List of Figures Figure 1. Global Hepatitis Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Hepatitis Therapeutics Market Share by Type: 2022 VS 2029 Figure 3. Hepatitis Vaccine Features Figure 4. Anti-Viral Drugs Features Figure 5. Global Hepatitis Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 6. Global Hepatitis Therapeutics Market Share by Application: 2022 VS 2029 Figure 7. Hepatitis A Case Studies Figure 8. Hepatitis B Case Studies Figure 9. Hepatitis C Case Studies Figure 10. Alcoholic Hepatitis Case Studies Figure 11. Others Case Studies Figure 12. Hepatitis Therapeutics Report Years Considered Figure 13. Global Hepatitis Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Hepatitis Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Hepatitis Therapeutics Market Share by Region: 2022 VS 2029 Figure 16. Global Hepatitis Therapeutics Market Share by Players in 2022 Figure 17. Global Top Hepatitis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Therapeutics as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Hepatitis Therapeutics Revenue in 2022 Figure 19. North America Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Hepatitis Therapeutics Market Share by Country (2018-2029) Figure 21. United States Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Hepatitis Therapeutics Market Share by Country (2018-2029) Figure 25. Germany Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Hepatitis Therapeutics Market Share by Region (2018-2029) Figure 33. China Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Hepatitis Therapeutics Market Share by Country (2018-2029) Figure 41. Mexico Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Hepatitis Therapeutics Market Share by Country (2018-2029) Figure 45. Turkey Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Hepatitis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Gilead Revenue Growth Rate in Hepatitis Therapeutics Business (2018-2023) Figure 48. Johnson & Johnson Revenue Growth Rate in Hepatitis Therapeutics Business (2018-2023) Figure 49. Bristol-Myers Squibb Company Revenue Growth Rate in Hepatitis Therapeutics Business (2018-2023) Figure 50. Merck & Co.Inc. Revenue Growth Rate in Hepatitis Therapeutics Business (2018-2023) Figure 51. AbbVie Inc. Revenue Growth Rate in Hepatitis Therapeutics Business (2018-2023) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Gilead Johnson & Johnson Bristol-Myers Squibb Company Merck & Co.Inc. AbbVie Inc.